Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04600596Completed

Photographic Food Recognition and Meal Size Estimation Before and After Roux-en-Y Gastric Bypass

Role: lead

NCT04933305Completed

Microstructure of Ingestive Behavior and Body Weight Loss After Roux-en-Y Gastric Bypass

Role: lead

NCT03747445Completed

Microstructural Analysis of Ingestive Behavior After Roux-en-Y Gastric Bypass - Pilot

Role: lead

NCT03440138Completed

Defining Benchmarks in Bariatric Surgery

Role: lead

All 4 trials loaded